Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

CLLS

Cellectis ADR

May 14 • 10:12AM ET

4.06

+0.08 2.01 %

Healthcare • Biotechnology • France • Micro • NASD

Peers: EDIT ALLO CRSP FATE PGEN

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.67	Insider Own	3.93%	Shs Outstand	100.60M	Perf Week	5.18%
Market Cap	293.66M	Forward P/E	-	EPS next Y	-0.73	Insider Trans	0.00%	Shs Float	69.48M	Perf Month	-0.73%
Enterprise Value	216.60M	PEG	-	EPS next Q	-0.26	Inst Own	14.57%	Short Float	0.52%	Perf Quarter	16.33%
Income	-67.60M	P/S	4.31	EPS this Y	-30.06%	Inst Trans	3.73%	Short Ratio	9.26	Perf Half Y	9.14%
Sales	68.15M	P/B	6.82	EPS next Y	16.72%	ROA	-20.69%	Short Interest	0.36M	Perf YTD	-16.12%
Book/sh	0.60	P/C	1.58	EPS next 5Y	-24.83%	ROE	-76.76%	52W High	5.48 -25.91%	Perf Year	194.20%
Cash/sh	2.57	P/FCF	-	EPS past 3/5Y	33.81% 18.84%	ROIC	-44.07%	52W Low	1.33 205.93%	Perf 3Y	133.33%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	56.25% -0.34%	Gross Margin	71.06%	Volatility	7.57% 5.01%	Perf 5Y	-73.79%
Dividend TTM	-	EV/Sales	3.18	EPS Y/Y TTM	-15.55%	Oper. Margin	-75.78%	ATR (14)	0.24	Perf 10Y	-86.47%
Dividend Ex-Date	-	Quick Ratio	1.52	Sales Y/Y TTM	43.21%	Profit Margin	-99.19%	RSI (14)	56.65	Recom	1.43
Dividend Gr. 3/5Y	- -	Current Ratio	1.52	EPS Q/Q	2.04%	SMA20	2.80%	Beta	2.92	Target Price	7.52
Payout	-	Debt/Eq	1.81	Sales Q/Q	-45.62%	SMA50	9.72%	Rel Volume	1.68	Prev Close	3.98
Employees	229	LT Debt/Eq	1.56	Earnings	May 11 AMC	SMA200	8.56%	Avg Volume	39.34K	Price	4.06
IPO	Mar 25, 2015	Option/Short	Yes / Yes	EPS/Sales Surpr.	30.31% -31.63%	Trades		Volume	10,079	Change	2.01%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)